Akamis Bio

Abingdon, United Kingdom · Founded 2006 · Privately Held (backing)

Operator of a clinical-stage oncology company intended to develop cancer gene therapies. Akamis Bio is based in Abingdon, United Kingdom and was founded in 2006. Its last reported valuation was $145 million in Jan 2023. It has raised $185 million.

Last reported valuation

$145.3M

Oct 2026

Priced at

—

Total raised

$184.6M

Last round

—

How much has Akamis Bio raised?

$184.6Macross 0 recorded rounds

Free account

More of Akamis Bio with a free account

·The complete investor list: 25 names
·Watch Akamis Bio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Akamis Bio investors

25 investors are on record for Akamis Bio, including Salica Investments, ARCH Venture Partners, Bristol-Myers Squibb and Revelation Partners. By type, the record holds 5 venture capital firms and 1 asset manager.

For fundraisers

Raising for a company like Akamis Bio?

25 investors have backed Akamis Bio.

See all 25 investors →

Frequently asked about Akamis Bio

How much has Akamis Bio raised?: Akamis Bio has raised $184.6M in total across 0 recorded funding rounds.